Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The invention was demonstrated by using genetic manipulations and 3D spheroid programs, mimicking the primary options of human stable tumorsTEL AVIV, Israel, July...
Spyridon P. Basourakos, MDBasourakos is a urologic oncology fellow at Mayo Clinic in Rochester, Minnesota. Andrews is a urologic oncologist with Mayo Clinic...
